Open-label phase I clinical trial of Ad5-EBOV in Africans in China.

about

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens.Prevention of Ebola virus disease through vaccination: where we are in 2018

P2860

Q44106019-043C35C3-E77C-47B1-9DEF-0E4D45BA6D55 Q57255380-19B39C77-E566-4CF5-B681-7BDD49082716

P2860

Open-label phase I clinical trial of Ad5-EBOV in Africans in China.

Item

http://www.wikidata.org/entity/Q40048316

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Open-label phase I clinical trial of Ad5-EBOV in Africans in China.

@en

type

Item

label

Open-label phase I clinical trial of Ad5-EBOV in Africans in China.

@en

altLabel

Open-label phase I clinical trial of Ad5-EBOV in Africans in China

@en

prefLabel

Open-label phase I clinical trial of Ad5-EBOV in Africans in China.

@en

P1476

Open-label phase I clinical trial of Ad5-EBOV in Africans in China.

@en

P2093

Guanjing Lang

http://www.w3.org/2001/XMLSchema#string

Guolan Wu

http://www.w3.org/2001/XMLSchema#string

Hainv Gao

http://www.w3.org/2001/XMLSchema#string

Hangping Yao

http://www.w3.org/2001/XMLSchema#string

Huilin Ou

http://www.w3.org/2001/XMLSchema#string

Jian Liu

http://www.w3.org/2001/XMLSchema#string

Jianzhong Shentu

http://www.w3.org/2001/XMLSchema#string

Jifang Sheng

http://www.w3.org/2001/XMLSchema#string

Jingjing Liu

http://www.w3.org/2001/XMLSchema#string

Lanjuan Li

http://www.w3.org/2001/XMLSchema#string

P2860

A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

Chimpanzee Adenovirus Vector Ebola Vaccine — Preliminary Report

Emergence of Zaire Ebola Virus Disease in Guinea

Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial.

Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial.

Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, doub

Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study.

Ebola Virus Disease, Democratic Republic of the Congo, 2014.

Ebola virus disease candidate vaccines under evaluation in clinical trials.

P304

1-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/21645515.2017.1342021

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28708962

http://www.w3.org/2001/XMLSchema#string

P921

Ebola virus

phase I clinical trial

P932

5612469

http://www.w3.org/2001/XMLSchema#string

Open-label phase I clinical trial of Ad5-EBOV in Africans in China.

about

P2860

P2860

Open-label phase I clinical trial of Ad5-EBOV in Africans in China.

description

name

type

label

altLabel

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932